Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Low-grade Fibromyxoid Sarcoma: Treatment Outcomes and Efficacy of Chemotherapy

FLORENCE CHAMBERLAIN, BODIL ENGELMANN, OMAR AL-MUDERIS, CHRISTINA MESSIOU, KHIN THWAY, AISHA MIAH, SHANE ZAIDI, ANASTASIA CONSTANTINIDOU, CHARLOTTE BENSON, SPYRIDON GENNATAS and ROBIN L. JONES
In Vivo January 2020, 34 (1) 239-245; DOI: https://doi.org/10.21873/invivo.11766
FLORENCE CHAMBERLAIN
1Sarcoma Unit, The Royal Marsden NHS Foundation Trust, London, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
BODIL ENGELMANN
1Sarcoma Unit, The Royal Marsden NHS Foundation Trust, London, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
OMAR AL-MUDERIS
1Sarcoma Unit, The Royal Marsden NHS Foundation Trust, London, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHRISTINA MESSIOU
1Sarcoma Unit, The Royal Marsden NHS Foundation Trust, London, U.K.
2Institute of Cancer Research, London, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KHIN THWAY
1Sarcoma Unit, The Royal Marsden NHS Foundation Trust, London, U.K.
2Institute of Cancer Research, London, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AISHA MIAH
1Sarcoma Unit, The Royal Marsden NHS Foundation Trust, London, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SHANE ZAIDI
1Sarcoma Unit, The Royal Marsden NHS Foundation Trust, London, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANASTASIA CONSTANTINIDOU
3Bank of Cyprus Oncology Center, Strovolos, Cyprus
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHARLOTTE BENSON
1Sarcoma Unit, The Royal Marsden NHS Foundation Trust, London, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SPYRIDON GENNATAS
1Sarcoma Unit, The Royal Marsden NHS Foundation Trust, London, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ROBIN L. JONES
1Sarcoma Unit, The Royal Marsden NHS Foundation Trust, London, U.K.
2Institute of Cancer Research, London, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: robin.jones4{at}nhs.net
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Magnetic resonance imaging of patient treated with concomitant chemoradiotherapy for a locally advanced inoperable pelvic low-grade fibromyxoid sarcoma.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Computed tomographic scan of patient treated with concomitant chemoradiotherapy, demonstrating development of new liver metastasis after 56 months.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Kaplan–Meier curve for overall survival of patients following first-line systemic chemotherapy for low-grade fibromyxoid sarcoma.

Tables

  • Figures
  • Table I.
  • Table II.
PreviousNext
Back to top

In this issue

In Vivo
Vol. 34, Issue 1
January-February 2020
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Low-grade Fibromyxoid Sarcoma: Treatment Outcomes and Efficacy of Chemotherapy
(Your Name) has sent you a message from In Vivo
(Your Name) thought you would like to see the In Vivo web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
9 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Low-grade Fibromyxoid Sarcoma: Treatment Outcomes and Efficacy of Chemotherapy
FLORENCE CHAMBERLAIN, BODIL ENGELMANN, OMAR AL-MUDERIS, CHRISTINA MESSIOU, KHIN THWAY, AISHA MIAH, SHANE ZAIDI, ANASTASIA CONSTANTINIDOU, CHARLOTTE BENSON, SPYRIDON GENNATAS, ROBIN L. JONES
In Vivo Jan 2020, 34 (1) 239-245; DOI: 10.21873/invivo.11766

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Low-grade Fibromyxoid Sarcoma: Treatment Outcomes and Efficacy of Chemotherapy
FLORENCE CHAMBERLAIN, BODIL ENGELMANN, OMAR AL-MUDERIS, CHRISTINA MESSIOU, KHIN THWAY, AISHA MIAH, SHANE ZAIDI, ANASTASIA CONSTANTINIDOU, CHARLOTTE BENSON, SPYRIDON GENNATAS, ROBIN L. JONES
In Vivo Jan 2020, 34 (1) 239-245; DOI: 10.21873/invivo.11766
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Low-grade Fibromyxoid Sarcoma With Massive Degeneration: A Case of Unusual Gross and Histological Features
  • Low-grade fibromyxoid sarcoma of the parapharyngeal space: an unusual location
  • Google Scholar

More in this TOC Section

  • Bioelectrical Impedance Analysis in the Diagnosis of Sarcopenia in Oncological Patients: The Sarco-Detect Study
  • Stage-dependent Expression of Autophagy-related Genes in Patients With Knee Osteoarthritis
  • Effects of Short-term High-dose Vitamin D Supplementation on Mineral Homeostasis in Healthy Young Adults
Show more Clinical Studies

Keywords

  • Low-grade fibromyxoid sarcoma
  • LGFMS
  • Chemotherapy
  • radiotherapy
  • chromosomal translocation
In Vivo

© 2026 In Vivo

Powered by HighWire